{"count": 8, "results": [{"_id": "36538862", "pmid": 36538862, "title": "Simvastatin therapy in higher dosages deteriorates bone quality: Consistent evidence from population-wide patient data and interventional mouse studies.", "journal": "Biomed Pharmacother", "authors": ["Leutner M", "Butylina M", "Matzhold C", "Klimek P", "Cuhaj C", "Bellach L", "Baumgartner-Parzer S", "Reiter B", "Preindl K", "Kautzky A", "Stimpfl T", "Thurner S", "Pietschmann P", "Fürnsinn C", "Kautzky-Willer A"], "date": "2023-02-01T00:00:00Z", "doi": "10.1016/j.biopha.2022.114089", "meta_date_publication": "2023 Feb", "meta_volume": "158", "meta_issue": "", "meta_pages": "114089", "score": 50258.39, "text_hl": "RESULTS: High-dose @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ impaired bone @<m>DISEASE_Sleep_Wake_Disorders</m> @DISEASE_MESH:D012893 @@@quality@@@ in male and ovariectomized @SPECIES_10090 @@@mice@@@. ", "citations": {"NLM": "Leutner M, Butylina M, Matzhold C, Klimek P, Cuhaj C, Bellach L, Baumgartner-Parzer S, Reiter B, Preindl K, Kautzky A, Stimpfl T, Thurner S, Pietschmann P, Fürnsinn C, Kautzky-Willer A. Simvastatin therapy in higher dosages deteriorates bone quality: Consistent evidence from population-wide patient data and interventional mouse studies. Biomed Pharmacother. 2023 Feb;158():114089. PMID: 36538862", "BibTeX": "@article{36538862, title={Simvastatin therapy in higher dosages deteriorates bone quality: Consistent evidence from population-wide patient data and interventional mouse studies.}, author={Leutner M and Butylina M and Matzhold C and Klimek P and Cuhaj C and Bellach L and Baumgartner-Parzer S and Reiter B and Preindl K and Kautzky A and Stimpfl T and Thurner S and Pietschmann P and Fürnsinn C and Kautzky-Willer A}, journal={Biomed Pharmacother}, volume={158}, pages={114089}}"}}, {"_id": "11675864", "pmid": 11675864, "title": "Nightmares and sleep disturbances with simvastatin and metoprolol.", "journal": "Ann Pharmacother", "authors": ["Boriani G", "Biffi M", "Strocchi E", "Branzi A"], "date": "2001-10-01T00:00:00Z", "doi": "10.1345/aph.1A079", "meta_date_publication": "2001 Oct", "meta_volume": "35", "meta_issue": "10", "meta_pages": "1292", "score": 50078.88, "text_hl": "Nightmares and @<m>DISEASE_Sleep_Wake_Disorders</m> @DISEASE_MESH:D012893 @@@sleep disturbances@@@ with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@.", "citations": {"NLM": "Boriani G, Biffi M, Strocchi E, Branzi A. Nightmares and sleep disturbances with simvastatin and metoprolol. Ann Pharmacother. 2001 Oct;35(10):1292. PMID: 11675864", "BibTeX": "@article{11675864, title={Nightmares and sleep disturbances with simvastatin and metoprolol.}, author={Boriani G and Biffi M and Strocchi E and Branzi A}, journal={Ann Pharmacother}, volume={35}, number={10}, pages={1292}}"}}, {"_id": "8904621", "pmid": 8904621, "title": "Absence of effects of prolonged simvastatin therapy on nocturnal sleep in a large randomized placebo-controlled study. Oxford Cholesterol Study Group.", "journal": "Br J Clin Pharmacol", "authors": ["Keech AC", "Armitage JM", "Wallendszus KR", "Lawson A", "Hauer AJ", "Parish SE", "Collins R"], "date": "1996-10-01T00:00:00Z", "doi": "10.1046/j.1365-2125.1996.439/1.x", "meta_date_publication": "1996 Oct", "meta_volume": "42", "meta_issue": "4", "meta_pages": "483-90", "score": 50051.38, "text_hl": "It has been suggested that lipophilic HMG CoA reductase inhibitors, like @CHEMICAL_Lovastatin @CHEMICAL_MESH:D008148 @@@lovastatin@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, may cause @<m>DISEASE_Sleep_Wake_Disorders</m> @DISEASE_MESH:D012893 @@@sleep disturbance@@@. 2. ", "citations": {"NLM": "Keech AC, Armitage JM, Wallendszus KR, Lawson A, Hauer AJ, Parish SE, Collins R. Absence of effects of prolonged simvastatin therapy on nocturnal sleep in a large randomized placebo-controlled study. Oxford Cholesterol Study Group. Br J Clin Pharmacol. 1996 Oct;42(4):483-90. PMID: 8904621", "BibTeX": "@article{8904621, title={Absence of effects of prolonged simvastatin therapy on nocturnal sleep in a large randomized placebo-controlled study. Oxford Cholesterol Study Group.}, author={Keech AC and Armitage JM and Wallendszus KR and Lawson A and Hauer AJ and Parish SE and Collins R}, journal={Br J Clin Pharmacol}, volume={42}, number={4}, pages={483-90}}"}}, {"_id": "8471404", "pmid": 8471404, "title": "The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolaemia.", "journal": "Br J Clin Pharmacol", "authors": ["Eckernäs SA", "Roos BE", "Kvidal P", "Eriksson LO", "Block GA", "Neafus RP", "Haigh JR"], "date": "1993-03-01T00:00:00Z", "meta_date_publication": "1993 Mar", "meta_volume": "35", "meta_issue": "3", "meta_pages": "284-9", "score": 50051.277, "text_hl": "It appears that the inherent hydrophobicity of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ does not increase the occurrence of @<m>DISEASE_Sleep_Wake_Disorders</m> @DISEASE_MESH:D012893 @@@sleep disturbances@@@ in this @SPECIES_9606 @@@patient@@@ population at a dose shown to elicit a characteristic hypolipidaemic response.", "citations": {"NLM": "Eckernäs SA, Roos BE, Kvidal P, Eriksson LO, Block GA, Neafus RP, Haigh JR. The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolaemia. Br J Clin Pharmacol. 1993 Mar;35(3):284-9. PMID: 8471404", "BibTeX": "@article{8471404, title={The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolaemia.}, author={Eckernäs SA and Roos BE and Kvidal P and Eriksson LO and Block GA and Neafus RP and Haigh JR}, journal={Br J Clin Pharmacol}, volume={35}, number={3}, pages={284-9}}"}}, {"_id": "8165193", "pmid": 8165193, "title": "In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors.", "journal": "Pharm Res", "authors": ["Saheki A", "Terasaki T", "Tamai I", "Tsuji A"], "date": "1994-02-01T00:00:00Z", "doi": "10.1023/a:1018975928974", "meta_date_publication": "1994 Feb", "meta_volume": "11", "meta_issue": "2", "meta_pages": "305-11", "score": 50043.074, "text_hl": "Among the HMG-CoA reductase inhibitors, @CHEMICAL_Lovastatin @CHEMICAL_MESH:D008148 @@@lovastatin@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ have central @DISEASE_Nervous_System_Diseases @DISEASE_MESH:D009422 @@@nervous system@@@ (CNS) side effects, such as @<m>DISEASE_Sleep_Wake_Disorders</m> @DISEASE_MESH:D012893 @@@sleep disturbance@@@, whereas @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@ does not. ", "citations": {"NLM": "Saheki A, Terasaki T, Tamai I, Tsuji A. In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors. Pharm Res. 1994 Feb;11(2):305-11. PMID: 8165193", "BibTeX": "@article{8165193, title={In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors.}, author={Saheki A and Terasaki T and Tamai I and Tsuji A}, journal={Pharm Res}, volume={11}, number={2}, pages={305-11}}"}}, {"_id": "7923304", "pmid": 7923304, "title": "A review of clinical trials comparing HMG-CoA reductase inhibitors.", "journal": "Clin Ther", "authors": ["Illingworth DR", "Tobert JA"], "date": "1994-05-01T00:00:00Z", "meta_date_publication": "1994 May-Jun", "meta_volume": "16", "meta_issue": "3", "meta_pages": "366-85; discussion 365", "score": 50042.17, "text_hl": "The side-effect profiles of all four drugs appeared similar, and earlier reports that suggested a higher incidence of @<m>DISEASE_Sleep_Wake_Disorders</m> @DISEASE_MESH:D012893 @@@sleep disorders@@@ in @SPECIES_9606 @@@patients@@@ treated with the more lipophilic drugs, @CHEMICAL_Lovastatin @CHEMICAL_MESH:D008148 @@@lovastatin@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, as compared with @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@, are not supported by more recent, controlled clinical trials. ", "citations": {"NLM": "Illingworth DR, Tobert JA. A review of clinical trials comparing HMG-CoA reductase inhibitors. Clin Ther. 1994 May-Jun;16(3):366-85; discussion 365. PMID: 7923304", "BibTeX": "@article{7923304, title={A review of clinical trials comparing HMG-CoA reductase inhibitors.}, author={Illingworth DR and Tobert JA}, journal={Clin Ther}, volume={16}, number={3}, pages={366-85; discussion 365}}"}}, {"_id": "26132393", "pmid": 26132393, "pmcid": "PMC4488854", "title": "Statin Effects on Aggression: Results from the UCSD Statin Study, a Randomized Control Trial", "journal": "PLoS One", "authors": ["Golomb BA", "Dimsdale JE", "Koslik HJ", "Evans MA", "Lu X", "Rossi S", "Mills PJ", "White HL", "Criqui MH"], "date": "2015-07-01T00:00:00Z", "doi": "10.1371/journal.pone.0124451", "meta_date_publication": "2015", "meta_volume": "10", "meta_issue": "7", "meta_pages": "e0124451", "score": 50037.766, "text_hl": "Statins (especially @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@) lowered @CHEMICAL_Testosterone @CHEMICAL_MESH:D013739 @@@testosterone@@@, and increased @<m>DISEASE_Sleep_Wake_Disorders</m> @DISEASE_MESH:D012893 @@@sleep problems@@@. ", "citations": {"NLM": "Golomb BA, Dimsdale JE, Koslik HJ, Evans MA, Lu X, Rossi S, Mills PJ, White HL, Criqui MH. Statin Effects on Aggression: Results from the UCSD Statin Study, a Randomized Control Trial PLoS One. 2015;10(7):e0124451. PMID: 26132393", "BibTeX": "@article{26132393, title={Statin Effects on Aggression: Results from the UCSD Statin Study, a Randomized Control Trial}, author={Golomb BA and Dimsdale JE and Koslik HJ and Evans MA and Lu X and Rossi S and Mills PJ and White HL and Criqui MH}, journal={PLoS One}, volume={10}, number={7}, pages={e0124451}}"}}, {"_id": "20199424", "pmid": 20199424, "title": "Nail-patella syndrome with an emphasis on the risk of renal and ocular findings.", "journal": "Pediatr Dermatol", "authors": ["Kamath S", "Bhagwandas K"], "date": "2010-01-01T00:00:00Z", "doi": "10.1111/j.1525-1470.2009.01051.x", "meta_date_publication": "2010 Jan-Feb", "meta_volume": "27", "meta_issue": "1", "meta_pages": "95-7", "score": 50036.723, "text_hl": "She had @DISEASE_Mental_Disorders @DISEASE_MESH:D001523 @@@behavioral abnormalities@@@ and @<m>DISEASE_Sleep_Wake_Disorders</m> @DISEASE_MESH:D012893 @@@sleep disturbances@@@. ", "citations": {"NLM": "Kamath S, Bhagwandas K. Nail-patella syndrome with an emphasis on the risk of renal and ocular findings. Pediatr Dermatol. 2010 Jan-Feb;27(1):95-7. PMID: 20199424", "BibTeX": "@article{20199424, title={Nail-patella syndrome with an emphasis on the risk of renal and ocular findings.}, author={Kamath S and Bhagwandas K}, journal={Pediatr Dermatol}, volume={27}, number={1}, pages={95-7}}"}}]}